PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Manead Khin
Episode 36: Novo Nordisk
23 minutes Posted Jan 1, 2026 at 7:00 pm.
Founding Story
Consolidation, Globalization, and the Road to Public Markets
Mastering Diabetes Through Incremental Excellence
GLP-1 Biology and the Reinvention of Metabolic Disease
Ozempic, Wegovy, and the Cultural Moment
People Who Made Their Mark
Competition, Pressure, and Strategic Discipline
What’s Next for Novo Nordisk?
Lessons from Novo Nordisk
0:00
23:34
Download MP3
Show notes
Send us Fan Mail Novo Nordisk’s rise is one of the most extraordinary stories in modern medicine. What began in 1920s Denmark as a response to a fatal disease evolved into a company that reshaped how the world treats diabetes, obesity, and metabolic illness. In this episode, we trace Novo Nordisk’s journey from the discovery of insulin and a decades-long rivalry between two Danish labs, to a landmark merger, global expansion, and steady leadership in diabetes care. We explore how the company ...